Fei Shen
FS
Fei Shen
Managing Director, Boehringer Ingelheim Venture Fund USA
Rate
About
Fei Shen is the Managing Director of Boehringer Ingelheim Venture Fund USA, where she focuses on investing in and supporting early-stage companies. She joined the Boehringer Ingelheim Venture Fund in 2020 and is located in Boston, MA. She currently serves on the Boards of Rgenta Therapeutics, ArrePath, xCures, and STRM.
Frequently asked
Who is Fei Shen?
Fei Shen is the Managing Director of Boehringer Ingelheim Venture Fund USA, where she focuses on investing in and supporting early-stage companies. She joined the Boehringer Ingelheim Venture Fund in 2020 and is located in Boston, MA. She currently serves on the Boards of Rgenta Therapeutics, ArrePath, xCures, and STRM.
What is Fei Shen's current role?
Fei Shen is currently Managing Director, Boehringer Ingelheim Venture Fund USA.
Comments
No comments yet. Be the first to share your take.
Profile
About Fei Shen
Fei Shen is Managing Director, Boehringer Ingelheim Venture Fund USA. This profile tracks their companies, funding activity, and news mentions across the AI ecosystem.